Celltrion, Inc is a biopharmaceutical company that specializes in researching, developing, manufacturing, and selling innovative therapeutics. Celltrion supplies medicines to over 100 countries, including the United States and Europe, and is the largest manufacturer and exporter of biosimilars in Korea. The company has received sales approval on its biosimilars in about 100 countries by US FDA and Europe EMA. Celltrion has R&D specialists and facilities for the development of biopharmaceuticals and novel therapeutics and is exploring various types of platform technologies. The company provides solutions for the entire biopharmaceutical business process, from R&D to clinical trials, regulatory affairs, production, and distribution. Celltrion has a production capacity of 250,000L and has acquired US FDA and Europe EMA cGMP certifications on all facilities.
Headquarters
13-6 Songdo-Dong, Yeonsu-Gu
Incheon; Incheon;
Postal Code: 406-840
Contact Details: Purchase the Celltrion Co.,Ltd. report to view the information.
Website: http://www.celltrion.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service